Published in Nat Rev Nephrol on July 23, 2013
Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis. Am J Nephrol (2015) 1.46
Vitamin D deficiency aggravates chronic kidney disease progression after ischemic acute kidney injury. PLoS One (2014) 0.89
The use of fibroblast growth factor 23 testing in patients with kidney disease. Clin J Am Soc Nephrol (2014) 0.86
Role of vitamin D in diabetes mellitus and chronic kidney disease. World J Diabetes (2016) 0.84
Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D. J Am Soc Nephrol (2016) 0.82
Renal Clearance of Mineral Metabolism Biomarkers. J Am Soc Nephrol (2015) 0.82
Chronic kidney disease and osteoporosis: evaluation and management. Bonekey Rep (2014) 0.81
Parathyroid hormone: critical bridge between bone metabolism and cardiovascular disease. Arterioscler Thromb Vasc Biol (2014) 0.81
Vitamin D resistance in chronic kidney disease (CKD). BMC Nephrol (2014) 0.80
Chronic kidney disease and the skeleton. Bone Res (2014) 0.79
Phosphate and FGF-23 homeostasis after kidney transplantation. Nat Rev Nephrol (2015) 0.79
FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice. Sci Rep (2015) 0.78
Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease. J Vet Intern Med (2017) 0.78
Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice. Nephrol Dial Transplant (2014) 0.78
Is nutritional vitamin D supplementation beneficial in dialysis patients? Clin J Am Soc Nephrol (2015) 0.76
Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism. Clin J Am Soc Nephrol (2015) 0.76
PTH signaling mediates perilacunar remodeling during exercise. Matrix Biol (2016) 0.76
Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease. J Vet Intern Med (2017) 0.75
FGF23 is associated with early post-transplant hypophosphataemia and normalizes faster than iPTH in living donor renal transplant recipients: a longitudinal follow-up study. Clin Kidney J (2016) 0.75
The Pas de Trois of Vitamin D, FGF23, and PTH. J Am Soc Nephrol (2016) 0.75
Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients. Ann Lab Med (2017) 0.75
Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature (1997) 13.77
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med (2008) 9.19
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet (2000) 7.41
FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int (2006) 7.02
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res (2003) 6.81
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A (2001) 6.70
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int (2011) 4.74
A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet (1995) 4.61
DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet (2006) 4.49
The parathyroid is a target organ for FGF23 in rats. J Clin Invest (2007) 4.47
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab (2002) 4.17
Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev (2005) 3.38
Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol (2006) 3.36
Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol (2008) 3.26
Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun (1998) 3.19
Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci U S A (2007) 3.13
Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int (2010) 3.04
Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology (2002) 3.00
Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab (2004) 2.83
Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin J Am Soc Nephrol (2009) 2.81
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest (2007) 2.79
Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem (2004) 2.72
alpha-Klotho as a regulator of calcium homeostasis. Science (2007) 2.71
Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem (2006) 2.68
Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int (2010) 2.61
Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med (2010) 2.55
FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun (2004) 2.52
Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology (1998) 2.48
FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest (2012) 2.41
Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology (2005) 2.36
Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol (2007) 2.31
Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci U S A (2011) 2.24
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci U S A (2009) 2.23
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transplant (2010) 2.23
Endocrine functions of bone in mineral metabolism regulation. J Clin Invest (2008) 2.19
PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol (2010) 2.19
Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int (2006) 2.10
Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int (2009) 2.10
Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int (2009) 2.09
1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol (2005) 2.08
Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. Am J Physiol Renal Physiol (2005) 2.05
Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients. Nephrol Dial Transplant (2011) 2.02
Increased parathyroid expression of klotho in uremic rats. Kidney Int (2010) 2.00
Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev (2012) 1.97
Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet (2010) 1.93
Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am J Hum Genet (2004) 1.92
Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int (2012) 1.82
Circulating αKlotho influences phosphate handling by controlling FGF23 production. J Clin Invest (2012) 1.80
FGF23 and disorders of phosphate homeostasis. Cytokine Growth Factor Rev (2005) 1.79
Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest (2006) 1.75
Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. FASEB J (2011) 1.74
Reduced plasma pyrophosphate levels in hemodialysis patients. J Am Soc Nephrol (2005) 1.68
On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest (1971) 1.66
Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest (1996) 1.63
Changes in fibroblast growth factor 23 during treatment of secondary hyperparathyroidism with alfacalcidol or paricalcitol. Nephrol Dial Transplant (2011) 1.63
Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol (2008) 1.60
A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J Clin Endocrinol Metab (2005) 1.56
A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism. Proc Natl Acad Sci U S A (2008) 1.56
Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone (2011) 1.52
Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study. Nephrol Dial Transplant (2009) 1.51
Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect. J Clin Invest (1992) 1.45
FGF-23 is elevated by chronic hyperphosphatemia. J Clin Endocrinol Metab (2004) 1.43
Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice. J Bone Miner Res (1989) 1.43
Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol (2012) 1.42
FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol (2010) 1.42
Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease. Exp Cell Res (2012) 1.41
Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations. Bone (2005) 1.40
Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia. J Clin Invest (2008) 1.38
Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res (2001) 1.38
Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur J Endocrinol (2006) 1.36
Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clin J Am Soc Nephrol (2011) 1.36
Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice. J Bone Miner Res (2010) 1.34
Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J Bone Miner Metab (2007) 1.31
Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD. Clin J Am Soc Nephrol (2009) 1.30
FGF23-parathyroid interaction: implications in chronic kidney disease. Kidney Int (2009) 1.25
FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone. J Bone Miner Res (2011) 1.25
Mechanisms of secondary hyperparathyroidism. Am J Physiol Renal Physiol (2002) 1.19
Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol Dial Transplant (2012) 1.18
Altered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice. PLoS One (2012) 1.18
Mechanism of FGF23 processing in fibrous dysplasia. J Bone Miner Res (2012) 1.17
Parathyroid hormone gene expression in hypophosphatemic rats. J Clin Invest (1995) 1.16
Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism. Nephrol Dial Transplant (2011) 1.12
Regulation of fibroblast growth factor-23 in chronic kidney disease. Nephrol Dial Transplant (2007) 1.12
Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia. J Clin Endocrinol Metab (2008) 1.11
Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res (1996) 1.11
Indirect regulation of PTH by estrogens may require FGF23. J Am Soc Nephrol (2009) 1.07
The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int (1973) 1.05
Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients. Am J Nephrol (2011) 1.03
Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway. Crit Rev Eukaryot Gene Expr (2012) 1.03
Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. J Clin Endocrinol Metab (2012) 1.02
The role of FGF23 in CKD--with or without Klotho. Nat Rev Nephrol (2012) 1.02
FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH. J Bone Miner Res (2011) 1.02
Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism. Eur J Endocrinol (2004) 1.01
FGF23 is a putative marker for bone healing and regeneration. J Orthop Res (2009) 0.98
Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism. Mayo Clin Proc (2004) 0.95
Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study. Nephrol Dial Transplant (2010) 0.95
Osteocyte messages from a bony tomb. Cell Metab (2007) 0.95
Metabolic acidosis increases fibroblast growth factor 23 in neonatal mouse bone. Am J Physiol Renal Physiol (2012) 0.92
A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells. Nephrol Dial Transplant (1996) 0.91
The parathyroid is a target organ for FGF23 in rats. J Clin Invest (2007) 4.47
Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats. Nephrol Dial Transplant (2006) 2.20
PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol (2010) 2.19
Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int (2009) 2.09
Calreticulin destabilizes glucose transporter-1 mRNA in vascular endothelial and smooth muscle cells under high-glucose conditions. Circ Res (2005) 1.60
Mechanisms of secondary hyperparathyroidism. Am J Physiol Renal Physiol (2002) 1.19
Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: correlation with posttranslational modification of the trans acting factor AUF1. J Am Soc Nephrol (2005) 1.09
The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism. J Clin Invest (2009) 1.01
Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion. Curr Opin Nephrol Hypertens (2008) 0.95
FGF23 and the parathyroid glands. Pediatr Nephrol (2010) 0.95
The mRNA decay promoting factor K-homology splicing regulator protein post-transcriptionally determines parathyroid hormone mRNA levels. FASEB J (2008) 0.91
Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology. Am J Physiol Renal Physiol (2009) 0.90
The protein phosphatase calcineurin determines basal parathyroid hormone gene expression. Mol Endocrinol (2004) 0.90
Calcineurin Abeta is central to the expression of the renal type II Na/Pi co-transporter gene and to the regulation of renal phosphate transport. J Am Soc Nephrol (2004) 0.88
Phosphate and the parathyroid. Kidney Int (2009) 0.86
Identification and characterization of cis-acting elements in the human and bovine PTH mRNA 3'-untranslated region. J Bone Miner Res (2004) 0.84
In vitro evidence that upstream of N-ras participates in the regulation of parathyroid hormone messenger ribonucleic acid stability. Mol Endocrinol (2006) 0.84
Human PTH gene regulation in vivo using transgenic mice. Am J Physiol Renal Physiol (2009) 0.83
The parathyroid hormone mRNA 3'-untranslated region AU-rich element is an unstructured functional element. J Biol Chem (2003) 0.82
Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD. Am J Physiol Renal Physiol (2009) 0.82
KSRP-PMR1-exosome association determines parathyroid hormone mRNA levels and stability in transfected cells. BMC Cell Biol (2009) 0.81
The calcium-sensing receptor regulates parathyroid hormone gene expression in transfected HEK293 cells. BMC Biol (2009) 0.81
FGF23 and the parathyroid. Adv Exp Med Biol (2012) 0.79
Characterization of cis-acting element in renal NaPi-2 cotransporter mRNA that determines mRNA stability. Am J Physiol Renal Physiol (2002) 0.77
Mutational analysis of the PTH 3'-untranslated region in parathyroid disorders. Clin Endocrinol (Oxf) (2006) 0.76
The complex regulation of HIC (Human I-mfa domain containing protein) expression. PLoS One (2009) 0.76
Micro-RNAs in the parathyroid: a new portal in understanding secondary hyperparathyroidism. Curr Opin Nephrol Hypertens (2016) 0.76